Perella Weinberg Partners Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,349	Closed	-$515K	–	39
2019 Q2	$515K	Sell	11,349 -8,082	-42%	-$376K	0.02%	213
2019 Q1	$99K	Buy	19,431 +1,905	+11%	+$94.9K	﹤0.01%	194
2018 Q4	$911K	Buy	+17,526	New	+$942K	0.06%	167
2018 Q2	–	Sell	-134,927	Closed	-$8.53M	–	198
2018 Q1	$8.53M	Buy	134,927 +72,499	+116%	+$4.66M	0.38%	78
2017 Q4	$3.83M	Sell	62,428 -39,118	-39%	-$2.45M	0.37%	73
2017 Q3	$6.47K	Sell	101,546 -27,752	-21%	-$1.62M	0.54%	44
2017 Q2	$7.2M	Buy	129,298 +89,311	+223%	+$4.86M	0.88%	30
2017 Q1	$2.17M	Buy	+39,987	New	+$2.19M	0.36%	42
2013 Q3	–	Sell	-19,490	Closed	-$871K	–	129
2013 Q2	$871K	Buy	+19,490	New	+$846K	0.06%	168

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perella Weinberg Partners Capital Management's BMY Position: Q3 2019 in Review

Perella Weinberg Partners Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 11,349 shares — an estimated $515K sold.

Perella Weinberg Partners Capital Management first reported a position in BMY in Q2 2013 and held it in 9 quarters. The position peaked at $8.53M in Q1 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Perella Weinberg Partners Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 11,349 Bristol-Myers Squibb shares in Q3 2019, an estimated $515K.
Perella Weinberg Partners Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 9 quarters.
Perella Weinberg Partners Capital Management's Bristol-Myers Squibb position peaked at $8.53M in Q1 2018.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.